Lipella Pharmaceuticals, Inc. financial statements
Lipella Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 536.36K | 10-K |
| Net income | −USD 5.02M | 10-K |
| Cash and equivalents | USD 2.18M | 10-Q |
Lipella Pharmaceuticals, Inc. financials on 6ix · Lipella Pharmaceuticals, Inc. on 6ix